Business Optimizer™ | Business Consultancy

Driving the commercial success of pharma and biotech clients and service providers through our proprietary toolbox of proven strategic methodologies, analytical approaches and targeted expertise.

Our Approach

The Arcas Group will improve the commercial success through

  1. Enhanced business operations
  2. Improved strategic insight and focus
  3. Stronger portfolio of offerings

Our Business Optimizer™ approach is customized to:
The unique needs and challenges of each client. Using a careful diagnostic process, we custom develop and manage our projects, and will bring you a fresh perspective from the confidence of expertise and experience.


Our Services

The Business Optimizer™ offering encompasses a comprehensive suite of well-proven analytical approaches and strategic methodologies. These consulting tools include:

  • Market Evaluator: Evaluation of market opportunities for products and services
  • Market Developer: Market readying of products and services
  • Market Optimizer™: Optimizing of market opportunity for products and services
  • Licensing Evaluator: Identification, assessment and brokering of licensing opportunities
  • Organization Optimizer™: 360º organizational review with structured improvements
  • Clip-Yourself-To-Order™: Proprietary approach to understanding the customer experience and recommend efficiency, effectiveness and experience enhancements
  • Compliance Evaluator™: Assessment of adherence to (regulatory) compliance and policies with structured improvements

Our Promise

Making the right strategic decisions is tough business. Often, every-day demands and pressures do not allow for sufficient reflective time to carefully analyze a strategic challenge or growth opportunity; or for the time to develop and implement a comprehensive strategy.

We realize that you have a wide range of consulting organizations available to support you in your business decisions. By choosing Arcas and Business OptimizerT, we guarantee you the best experience in customer-service, strategic insight and project execution. Additionally, you can expect:

  • Deep insight in domestic and international healthcare markets resulting in a limited learning curve and start-up times;
  • Broad and deep therapy area expertise; particularly in oncology, hematology, psychiatry, cardiology, gastroenterology, and diabetes, and also other therapy areas such as infectious diseases, dermatology, internal medicine;
  • Flexibility in project and collaborative approach;
  • Established links with team of global healthcare experts (medical thoughtleaders, strategic marketing, financial analysis, pricing and reimbursement, pharmaceutical distribution);
  • Agile infrastructure that is readily deployable and with limited overhead costs.

Our Experience

Our team has a strong track record in strategic and management consultancy. A list of sample projects can be found below as well as a selection of healthcare and non-healthcare clients previously advised. Should you want to receive more detailed information on our past experience or client references, please contact us here.

Sample projects:

  • Market assessment (cervical cancer vaccine, cholesterol-lowering agent, anti-diabetic compound, new oncology therapy, growth strategies for medical services company);
  • Product and service enhancement (new indication for dermatology product, launch of consumer products, medical research services);
  • Commercial due diligence (French pharmaceutical company, biotech company in UK, dermatology portfolio of US-based pharmaceutical company);
  • Licensing (anti-inflammatory product, psychiatry drugs, optimizing in-licensing process);
  • Organizational issues (creating biotech spin-off, pharmaceutical distribution, setting up account management, process enhancement in IT organization).

Selection of healthcare clients previously advised:

Allergan
AstraZeneca
Bioglan
Boehringer Ingelheim
Cambridge Antibody Technology
Cephalon
CSL
Chugai Rhone Poulenc Rorer
Dimethaid
Eli Lilly
Gilead
InterMune
Novo Nordisk
Pfizer
Pharmacia
Pharmagene
Schering Plough
SkyePharma

Selection of non-healthcare clients previously advised:

ABN AMRO
Frikifrisch, GmBH
The Greenery
ING Bank
Koninklijke Numico
Koninklijke De Ruijter
Ohra
KPN
Origin
Sara Lee Douwe Egberts
SG Cowen
Unilever